Other planned ONCAs


More
Information

BCCT plans summaries of off-label, overlooked or novel cancer approaches (ONCAs) to include these:

  • Bisphosphonates
  • Chloroquine
  • Chloroquine
  • Cimetadine
  • Clarithromycin
  • Gossypol
  • Interleukin 2 with taurolidine
  • Low-dose cyclophosphamide
  • Low-dose immune checkpoint inhibitors
  • Metronomic dose chemotherapy
  • Mifepristone
  • Noscapine
  • Persantine

More Information

In the News